title: Iron supplement in cancer patients receiving erythropoietin.
authors.forename: Paolo
authors.initials: P
authors.lastname: Pedrazzoli
authors.forename: Cinzia
authors.initials: C
authors.lastname: Tullio
authors.forename: Giulio
authors.initials: G
authors.lastname: Cerea
authors.forename: Salvatore
authors.initials: S
authors.lastname: Siena
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000008:administration & dosage*; D007505:Iron-Dextran Complex / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D007505:Iron-Dextran Complex; D007501:Iron